Alzamend Neuro, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
A Schedule 13D/A filing reveals significant insider selling by Ault Lending, LLC, an entity associated with Milton C. Ault, III, in Alzamend Neuro, Inc. common stock.
NASDAQ
Milton C. Ault, III and affiliated entities updated their beneficial ownership in Alzamend Neuro, Inc., disclosing significant common stock sales by Ault Lending, LLC.
NASDAQ
Milton C. Ault, III and affiliated entities have updated their beneficial ownership in Alzamend Neuro, Inc., disclosing significant share sales and conversions.
NASDAQ
Milton C. Ault, III and affiliated entities collectively hold a 13.3% beneficial ownership in Alzamend Neuro, Inc., with Ault Lending, LLC converting preferred stock and selling common shares.
NASDAQ
Milton C. Ault III and affiliated entities have updated their beneficial ownership in Alzamend Neuro, Inc., reporting a 15.9% stake and recent common stock sales.
NASDAQ
SCHEDULE: Alzamend Neuro Major Shareholder Updates Beneficial Ownership and Reports Recent Stock Sales
Milton C. Ault, III and affiliated entities have updated their beneficial ownership in Alzamend Neuro, Inc., reporting a combined 18.5% stake and recent sales of common stock by Ault Lending, LLC.